X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs DR. REDDYS LAB - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA DR. REDDYS LAB FULFORD INDIA/
DR. REDDYS LAB
 
P/E (TTM) x 398.8 29.7 1,344.1% View Chart
P/BV x 6.2 2.9 213.7% View Chart
Dividend Yield % 0.1 0.9 9.1%  

Financials

 FULFORD INDIA   DR. REDDYS LAB
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
DR. REDDYS LAB
Mar-17
FULFORD INDIA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs9423,397 27.7%   
Low Rs4502,560 17.6%   
Sales per share (Unadj.) Rs691.4856.5 80.7%  
Earnings per share (Unadj.) Rs11.578.0 14.7%  
Cash flow per share (Unadj.) Rs15.4139.9 11.0%  
Dividends per share (Unadj.) Rs2.0020.00 10.0%  
Dividend yield (eoy) %0.30.7 42.8%  
Book value per share (Unadj.) Rs380.0739.8 51.4%  
Shares outstanding (eoy) m3.90165.74 2.4%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x1.03.5 29.0%   
Avg P/E ratio x60.738.2 158.9%  
P/CF ratio (eoy) x45.321.3 212.9%  
Price / Book Value ratio x1.84.0 45.5%  
Dividend payout %17.425.7 68.0%   
Avg Mkt Cap Rs m2,714493,632 0.5%   
No. of employees `0000.422.7 2.0%   
Total wages/salary Rs m50531,068 1.6%   
Avg. sales/employee Rs Th6,073.06,259.0 97.0%   
Avg. wages/employee Rs Th1,137.41,369.8 83.0%   
Avg. net profit/employee Rs Th100.7569.7 17.7%   
INCOME DATA
Net Sales Rs m2,696141,961 1.9%  
Other income Rs m1251,715 7.3%   
Total revenues Rs m2,822143,676 2.0%   
Gross profit Rs m-4624,722 -0.2%  
Depreciation Rs m1510,266 0.1%   
Interest Rs m10634 1.5%   
Profit before tax Rs m5415,537 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m0349 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m102,965 0.3%   
Profit after tax Rs m4512,921 0.3%  
Gross profit margin %-1.717.4 -9.9%  
Effective tax rate %17.719.1 92.6%   
Net profit margin %1.79.1 18.2%  
BALANCE SHEET DATA
Current assets Rs m1,73896,837 1.8%   
Current liabilities Rs m54584,199 0.6%   
Net working cap to sales %44.38.9 497.2%  
Current ratio x3.21.2 277.5%  
Inventory Days Days4873 66.1%  
Debtors Days Days498 4.4%  
Net fixed assets Rs m12102,552 0.0%   
Share capital Rs m39829 4.7%   
"Free" reserves Rs m1,443121,792 1.2%   
Net worth Rs m1,482122,621 1.2%   
Long term debt Rs m05,449 0.0%   
Total assets Rs m2,077218,165 1.0%  
Interest coverage x6.725.5 26.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.7 199.5%   
Return on assets %2.66.2 42.0%  
Return on equity %3.010.5 28.6%  
Return on capital %4.312.9 33.4%  
Exports to sales %054.6 0.0%   
Imports to sales %24.59.4 261.5%   
Exports (fob) Rs mNA77,520 0.0%   
Imports (cif) Rs m65913,274 5.0%   
Fx inflow Rs m1781,670 0.0%   
Fx outflow Rs m67326,355 2.6%   
Net fx Rs m-65655,315 -1.2%   
CASH FLOW
From Operations Rs m9021,444 0.4%  
From Investments Rs m105-18,404 -0.6%  
From Financial Activity Rs m-14-3,692 0.4%  
Net Cashflow Rs m181-1,144 -15.8%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 5.4 70.4%  
FIIs % 0.1 35.3 0.3%  
ADR/GDR % 0.0 18.5 -  
Free float % 21.2 15.3 138.6%  
Shareholders   4,783 75,885 6.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   ORCHID PHARMA LTD  STERLING BIOTECH  ASTRAZENECA PHARMA  SUVEN LIFE  IPCA LABS  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS